Biocompatibilities and biodegradation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate)s produced by a model metabolic reaction-based system

BMC Microbiology

Suchada Chanprateep Napathorn¹ 

[1] Department of Microbiology, Faculty of Science, Chulalongkorn University, Phayathai Road, Patumwan 10330, Bangkok, Thailand

关键词: Cytotoxicity;    Cytokines;    Biodegradation;    PHBV;    Block copolymer;    Random copolymer;    Polyhydroxyalkanoates;    Biodegradable polymer;    Biocompatibility;   

Others  :  1090770
DOI  :  10.1186/s12866-014-0285-4

 received in 2014-07-28, accepted in 2014-11-04,  发布年份 2014

【 摘 要 】

Background

This study evaluated the biocompatibilities of random and putative block poly(3-hydroxybutyrate-co-3-hydroxyvalerate)s (PHBVs) produced by a metabolic reaction-based system. The produced PHBVs were fractionated, and the copolymer sequence distributions were analyzed using ¹H and ¹³C NMR spectroscopy. The thermal properties were analyzed using differential scanning calorimetry (DSC). Mechanical tests were conducted using a universal testing machine. The in vitro cytotoxicities of films composed of random PHBVs and putative block PHBVs were investigated against three types of mammalian cells. The surfaces of the copolymer films and the morphologies of the cells were qualitatively monitored using scanning electron microscopy (SEM) and atomic force microscopy (AFM).

Results

Films composed of poly(3-hydroxybutyrate) (PHB), random PHBVs, putative block PHBVs, polystyrene and polyvinylchloride were prepared and characterized. The diad and triad sequence distributions indicated that the PHBVs produced via the fed-batch cultivation using two different feed systems resulted in two types of copolymers: random PHBVs and putative block PHBVs. The monomer compositions and sequence distributions strongly affected the thermal and mechanical properties. The mechanical integrity and characteristics of the film surfaces changed with the HV content. Notably, the random PHBVs possessed different mechanical properties than the putative block PHBVs. The biocompatibilities of these films were evaluated in vitro against three types of mammalian cells: L292 mouse connective tissue, human dermal fibroblast and Saos-2 human osteosarcoma cells. None of the PHBV films exhibited cytotoxic responses to the three types of mammalian cells. Erosion of the PHA film surfaces was observed by scanning electron microscopy and atomic force microscopy. The production of transforming growth factor-β-1 and interleukin-8 was also examined with regards to the usefulness of PHB and PHBV as biomaterials for regenerative tissue. The production of IL-8, which is induced by PHB and PHBVs, may be used to improve and enhance the wound-healing process because of deficiencies of IL-8 in the wound area, particularly in problematic wounds.

Conclusion

Taken together, the results support the use of PHB and the random and putative block PHBVs produced in this study as potential biomaterials in tissue engineering applications for connective tissue, bone and dermal fibroblast reconstruction.

【 授权许可】

   
2014 Napathorn; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Evans ND, Gentleman E, Polak JM: Scaffolds for stem cells. Mater Today 2006, 9:26-33.
• [2]Taylor MS, Daniels AU, Andriano KP, Heller JJ: Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. Appl Biomater 1994, 5(2):151-157.
• [3]Seal BL, Otero TC, Panitch A: Polymeric biomaterial for tissue and organ regeneration. Mat Sci Eng Res 2001, 34(4–5):147-230.
• [4]Chen GQ, Wu Q: The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 2005, 26(33):6565-6578.
• [5]Misra SK, Valappil SP, Roy I, Boccaccini AR: Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 2006, 7(8):2249-2258.
• [6]Wang L, Wang ZH, Shen CY, You ML, Xiao JF, Chen GQ: Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells. Biomaterials 2010, 31(7):1691-1698.
• [7]Ahmed T, Marçal H, Lawless M, Wanandy NS, Chiu A, Foster LJR: Polyhydroxybutyrate and its copolymer with polyhydroxyvalerate as biomaterials: Influence on progression of stem cell cycle. Biomacromolecules 2010, 11(10):2707-2715.
• [8]Chan RTH, Russell RA, Marçal H, Lee TH, Holden PJ, Foster LJR: BioPEGylation of polyhydroxybutyrate promotes nerve cell health and migration. Biomacromolecules 2014, 15(1):339-349.
• [9]Shishatskaya EI, Volova TG, Puzyr AP, Mogilnaya OA, Efremov SN: Tissue response to the implantation of biodegrdable polyhydroxyalkanoate sutures. J Mater Sci-Mater Med 2004, 15(6):719-728.
• [10]Gogowleski S, Jovanovic M, Perren SM, Dillon JG, Hughes MKJ: Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). Biomed Mater Res 1993, 27(9):1135-1148.
• [11]Tesema Y, Raghavan D, Stubbs JJ: Bone cell viability on collagen immobilized poly(3-hydroxybutrate-co-3-hydroxyvalerate) membrane: Effect of surface chemistry. Appl Polym Sci 2004, 93(5):2445-2453.
• [12]Deng Y, Lin XS, Zheng Z, Deng JG, Chen JC, Ma H, Chen GQ: Poly(hydroxybutyrate-co-hydroxyhexanoate) promoted production of extracellular matrix of articular cartilage chondrocytes in vitro. Biomaterials 2003, 24(23):4273-4281.
• [13]Santos AR, Ferreira BMP, Duek EAR, Dolder H, Wada RS, Wada MLF: Differentiation pattern of Vero cells cultured on poly(L-lactic acid)/poly(hydroxybutyrate-co-hydroxyvalerate) blends. Artif Organs 2004, 28(4):381-389.
• [14]Williams SF, Martin DP, Horowitz DM, Peoples OP: PHA applications: addressing the price performance issue: I. Tissue engineering. Int J Biol Macromol 1999, 25:111-121.
• [15]Chen LJ, Wang M: Production and evaluation of biodegradable composites based on PHB-PHV copolymer. Biomaterials 2002, 23(13):2631-2639.
• [16]Meng W, Kim SY, Yuan J, Kim JC, Kwon OH, Kawazoe N, Chen G, Ito Y, Kang IK: Electrospun PHBV/collagen composite nanofibrous scaffolds for tissue engineering. J Biometer Sci Polym Ed 2007, 18(1):81-94.
• [17]Chanprateep S: Current Trends in Biodegradable Polyhydroxyalkanoates. J Biosci Bioeng 2010, 110(6):621-632.
• [18]Leor J, Landa N, Cohen S: Stem cell and gene-based therapy. In Frontiers in Regenerative Medicine. Edited by Battler A, Jonathan L. Springer-Verlag London Limited, United Kingdom; 2006:3-16.
• [19]Langer R, Tirrell DA: Designing materials for biology and medicine. Nature 2004, 428:487-492.
• [20]Jagur-Grodzinski J: Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general review of recent studies. J Polym Adv Technol 2006, 17(6):395-418.
• [21]Boxman ILA, Ruwhof C, Boerman OC, Löwik CWGM, Ponec M: Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1. Arch Dermatol Res 1996, 288:391-398.
• [22]Rennekampff HO, Hansbrough JF, Kiessig V, Dore C, Sticherling M, Schroder JM: Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000, 93(1):41-54.
• [23]Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A: Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care 2013, 2(5):215-224.
• [24]Chanprateep S, Abe N, Shimizu H, Shioya S: Multivariable control of alcohol concentrations in the production of polyhydroxyalkanoates (PHAs) by Paracoccus denitrificans. Biotechnol Bioeng 2001, 74(2):116-124.
• [25]Chanprateep S, Kikuya K, Shimizu H, Shioya S: Model predictive control for biodegradable polyhydroxyalkanoates production in fed-batch culture. J Biotechnol 2002, 95(2):157-169.
• [26]Chanprateep S, Kikuya K, Seki S, Takawa S, Shimizu H, Shioya S: Non-isothermal crystallization kinetics of biodegradable random poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and block one. J Chem Eng Jpn 2003, 36(6):639-646.
• [27]Chanprateep S, Shimizu H, Shioya S: Characterization and enzymatic degradation of microbial copolyester P(3HB-co-3HV)s produced by metabolic reaction model based system. Polym Degrad Stab 2006, 91(12):2941-2950.
• [28]Tripathi L, Wu LP, Dechuan M, Chen J, Wu Q, Chen GQ: Pseudomonas putida KT2442 as a platform for the biosynthesis of polyhydroxyalkanoates with adjustable monomer contents and compositions. Bioresour Technol 2013, 142:225-231.
• [29]Ishihara Y, Shimizu H, Shioya S: Mole fraction control of poly(3-hydroxy-butyric-co-3-hydroxyvaleric) acid in fed-batch culture of Alcaligenes eutrophus. J Ferment Bioeng 1996, 81:422-428.
• [30]Kamiya N, Yamanoto Y, Inoue Y, Chujo R, Doi Y: Microstructure of bacterially synthesized poly(3-hydroxybutyrate-co-3-hydroxyvalerate). Macromolecules 1989, 22:1676-1682.
• [31]Doi Y: Microbial polyesters. VCH publishers, New York; 1990.
• [32]Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, Woodley DT, Li W: A “traffic control” role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 2006, 172(7):1093-1105.
• [33]Chuaha J, Yamada M, Taguchi S, Sudesh K, Doi Y, Numata K: Biosynthesis and characterization of polyhydroxyalkanoate containing 5-hydroxyvalerate units: Effects of 5HV units on biodegradability, cytotoxicity, mechanical and thermal properties. Polym Degrad Stab 2013, 98(1):331-338.
• [34]Yang X, Zhao K, Chen GQ: Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates. Biomaterials 2002, 23(5):1391-1397.
• [35]Saito T, Tomita K, Juni K, Ooba K: In vivo and in vitro degradation of poly(3-hydroxybutyrate) in rat. Biomaterials 1991, 12(3):309-312.
• [36]Torun KG, Kenar H, Hasirci N, Hasirci V: Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue engineering. Biomaterials 2003, 24(11):1949-1958.
• [37]Williams SF, Martin DP, Williams SF, Martin DP: Applications of PHAs in Medicine and Pharmacy. In Biopolymers for medical and pharmaceutical applications: Humic Substances, Polyisoprenoids, Polyesters, and Polysaccharides. Volume 1. Edited by Steinbuchel A, Marchessault RH. Wiley-VCH, Germany; 2005:89-125.
• [38]Wang YJ, Ke Y, Ren L, Wu G, Chen XF, Zhao QC: Surface engineering of PHBV by covalent collagen immobilization to improve cell compatibility. J Biomed Mater Res A 2009, 88(3):616-627.
• [39]Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83(3):835-870.
• [40]Hsu A, Mustoe TA: The principles of wound healing. In Plastic Surgery Secrets Plus. Edited by Weinzweig J. Elsevier Academic Press, San Diego, CA; 2010:3-7.
• [41]Lv C, Dai H, Xing X, Zhang J: The systematic effects of chitosan on fibroblasts derived from hypertrophic scars and keloids.Indian J Dermatol Venereol Leprol 2012, 78(4):520.
• [42]Volova T, Shishatskaya E, Sevastianov V, Efremov S, Mogilnaya O: Results of biomedical investigations of PHB and PHB/PHV fibers. Biochem Eng J 2003, 16(2):125-133.
• [43]Valappil SP, Misra SK, Boccaccini AR, Roy I: Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses. Expert Rev Med Devices 2006, 3(6):853-868.
• [44]ASTM, D882–91: Allen R, Baldini N, Donofrio P, Gutman E, Keefe E, Kramer J, Leinweber C, Mayer V (Eds): Standard test methods for tensile properties of thin plastic sheeting In Annual Book of ASTM Standards. ASTM International Publishers, Philadelphia, PA; 1993.
• [45]ISO 10993-5: Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity. Association for the Advancement of Medication Instrumentation. International Organization for Standardization, Geneva, Switzerland; 2009.